|Bid||1.4500 x 1200|
|Ask||1.7600 x 800|
|Day's range||1.4800 - 1.5800|
|52-week range||1.4550 - 5.0000|
|Beta (5Y monthly)||0.86|
|PE ratio (TTM)||N/A|
|Earnings date||01 Mar 2022 - 07 Mar 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||9.20|
OptiNose (OPTN) has been struggling lately, but the selling pressure may be coming to an end soon.
The heavy selling pressure might have exhausted for OptiNose (OPTN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
OptiNose (OPTN) delivered earnings and revenue surprises of 13.51% and -8.68%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?